SLC2A1 and neoplasm: Indeed, the GPx2 KD tumor expressed notably higher levels of glucose transporter GLUT1 (SLC2A1), aldolase-A (ALDOA), phosphoglycerate kinase (PGK1), and lactate dehydrogenase A (LDHA) than in the control tumor (Fig. 6 B and C).